IN8bio Inc.
INAB | NASDAQ
$1.11
+$0.05 (+4.72%)
Sep 22, 2026, 11:34 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 500K | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -500K | -500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -18.84M | -19.16M | -19.44M | -20.66M | -23.89M | -27.43M | -30.44M | -32.21M | -32.29M | -31.37M | -30.34M | -30.21M | -30.44M | -29.9M | -28.52M | -26.57M | -22.56M | -18.44M | -14.65M | -11.12M | -9.41M | -9.23M |
Interest Income | 534K | 487K | 421K | 394K | 304K | 257K | 230K | 166K | 143K | 83K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -18.67M | -18.98M | -19.44M | -20.66M | -23.89M | -27.43M | -30.44M | -31.88M | -31.96M | -31.04M | -30.01M | -30.21M | -30.44M | -29.9M | -28.52M | -26.57M | -22.56M | -18.44M | -14.65M | -11.12M | -9.41M | -9.23M |
Net Income | -18.67M | -18.98M | -19.44M | -20.66M | -23.89M | -27.43M | -30.44M | -31.88M | -31.96M | -31.04M | -30.01M | -30.21M | -30.44M | -29.9M | -28.52M | -26.57M | -22.56M | -18.44M | -14.65M | -11.12M | -9.41M | -9.23M |
Selling & General & Admin | 9.34M | 9.62M | 9.65M | 9.9M | 10.76M | 11.58M | 12.64M | 13.08M | 13.73M | 13.78M | 13.51M | 14.31M | 14.07M | 14.17M | 14.46M | 13.75M | 12.64M | 9.95M | 7.31M | 4.97M | 3.55M | 3.66M |
Research & Development | 9.86M | 9.85M | 10.21M | 11.16M | 12.36M | 15.03M | 16.96M | 17.89M | 18.37M | 17.35M | 16.83M | 16.23M | 16.7M | 16.07M | 14.06M | 12.83M | 9.92M | 8.48M | 7.35M | 6.14M | 5.85M | 5.57M |
Other Expenses | -704K | -811K | -421K | -394K | 764K | 811K | 838K | 1.23M | 187K | 247K | n/a | -330K | -330K | -330K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 18.5M | 18.66M | 19.44M | 20.66M | 23.89M | 27.43M | 30.44M | 32.21M | 32.29M | 31.37M | 30.34M | 30.21M | 30.44M | 29.9M | 28.52M | 26.57M | 22.56M | 18.44M | 14.65M | 11.12M | 9.41M | 9.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.06M | 19.16M | 19.44M | 20.66M | 23.89M | 27.43M | 30.44M | 32.21M | 32.29M | 31.37M | 30.34M | 30.21M | 30.44M | 29.9M | 28.52M | 26.57M | 22.56M | 18.44M | 14.65M | 11.12M | 9.41M | 9.23M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 19.47M | 4.37M | 4.37M | 4.54M | 4.12M | 2.78M | 1.89M | 1.58M | 1.5M | 1.44M | 1.19M | 1.05M | 949.08K | 824.42K | 818.17K | 722.05K | 627.62K | 626.68K | 626.04K | 625.15K | 625.15K | 645.15K |
Shares Outstanding (Diluted) | 19.47M | 4.37M | 4.37M | 4.54M | 4.12M | 2.78M | 1.89M | 1.58M | 1.5M | 1.44M | 1.19M | 1.05M | 949.08K | 824.42K | 818.17K | 722.05K | 627.62K | 626.68K | 626.04K | 625.15K | 625.15K | 645.15K |
EPS (Basic) | -2.77 | -3.76 | -2.67 | -2.24 | -1.54 | -0.49 | -0.62 | -0.75 | -0.83 | -0.91 | -1.01 | -1.12 | -1.23 | -1.34 | -1.37 | -1.36 | -1.20 | -0.98 | -0.77 | -0.58 | -0.49 | -0.52 |
EPS (Diluted) | -2.77 | -3.76 | -2.67 | -2.24 | -1.54 | -0.49 | -0.62 | -0.75 | -0.83 | -0.91 | -1.01 | -1.12 | -1.23 | -1.34 | -1.37 | -1.36 | -1.20 | -0.98 | -0.77 | -0.58 | -0.49 | -0.52 |
EBITDA | -17.21M | -16.85M | -17.25M | -18.26M | -20.28M | -23.92M | -26.94M | -28.39M | -29.56M | -28.58M | -27.51M | -27.98M | -28.61M | -28.44M | -27.42M | -25.59M | -21.63M | -17.58M | -13.87M | -10.54M | -9.01M | -9M |
EBIT | -13.98M | -19.18M | -19.75M | -20.94M | -23.13M | -26.61M | -29.6M | -30.97M | -32.1M | -31.13M | -30.01M | -30.21M | -30.44M | -29.9M | -28.52M | -26.57M | -22.56M | -18.44M | -14.65M | -11.12M | -9.41M | -9.23M |
Depreciation & Amortization | 1.55M | 2.33M | 2.5M | 2.68M | 2.85M | 2.69M | 2.66M | 2.58M | 2.54M | 2.54M | 2.5M | 2.23M | 1.82M | 1.46M | 1.1M | 986K | 939K | 855K | 788K | 576K | 399K | 231K |
Add to Watchlist
Select watchlists to add or remove INAB